Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide.

Abstract : PURPOSE: The aim of this study is to define and illustrate metrics for the external evaluation of a population model. MATERIALS AND METHODS: In this paper, several types of metrics are defined: based on observations (standardized prediction error with or without simulation and normalized prediction distribution error); based on hyperparameters (with or without simulation); based on the likelihood of the model. All the metrics described above are applied to evaluate a model built from two phase II studies of gliclazide. A real phase I dataset and two datasets simulated with the real dataset design are used as external validation datasets to show and compare how metrics are able to detect and explain potential adequacies or inadequacies of the model. RESULTS: Normalized prediction errors calculated without any approximation, and metrics based on hyperparameters or on objective function have good theoretical properties to be used for external model evaluation and showed satisfactory behaviour in the simulation study. CONCLUSIONS: For external model evaluation, prediction distribution errors are recommended when the aim is to use the model to simulate data. Metrics through hyperparameters should be preferred when the aim is to compare two populations and metrics based on the objective function are useful during the model building process.
Type de document :
Article dans une revue
Pharmaceutical Research / Pharmaceutical Research (Dordrecht), 2006, 23 (9), pp.2036-49. <10.1007/s11095-006-9067-5>
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00189557
Contributeur : Thu Thuy Nguyen <>
Soumis le : mercredi 21 novembre 2007 - 12:41:05
Dernière modification le : mardi 11 octobre 2016 - 14:36:06
Document(s) archivé(s) le : lundi 12 avril 2010 - 03:03:52

Identifiants

Collections

Citation

Karl Brendel, Emmanuelle Comets, Céline Laffont, Christian Laveille, France Mentré. Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide.. Pharmaceutical Research / Pharmaceutical Research (Dordrecht), 2006, 23 (9), pp.2036-49. <10.1007/s11095-006-9067-5>. <inserm-00189557>

Partager

Métriques

Consultations de
la notice

317

Téléchargements du document

522